Übersetzung für "Therapieentscheidung" in Englisch

The data on arterial stiffness provides essential support to your physician’s treatment decision.

Table: ANCA persistence or rise should influence therapeutic decision.

The therapy decision is not dependent on the origin of the increased ventricular rate.

Due to the high level of reliability, and the volume calculation, it can be applied to decisions affecting therapy.

Also a documented impairment of the motility would influence the decision on the therapy.

However, molecular markers could help them to make the right treatment decision.

The risk of making the wrong therapy decision is increased many times over.

The decision for therapy is most often made on the basis of clinical examination and ultrasound.

A treatment decision must therefore consider the stage of the process which the patient is in.

The LibreView Software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

The patient’s personal wishes, needs and situation are addressed in all treatment decisions.

This allows more specialists to be involved immediately in diagnosis and therapy decisions in critical emergency situations.

So-called tumor markers are often the key to a precise diagnosis and a decision in favor of certain treatment for cancer.

It is sound clinical practice to base treatment on susceptibility testing of the bacteria isolated from the animal.

Nevertheless, caution should be exercised and the risks and benefits of this combination or co-treatment with other potent diuretics should be considered prior to the decision to use.

It is sound clinical practice to base treatment on susceptibility testing of the bacteria isolated from the animal.

If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of target bacteria.

MRI can assist the management decision as to whetheror not to proceed with arthroscopy.

In the mid-term, we will also increasingly focus on molecular tumor diagnostics in which we develop products for the detection of point mutations in ocogenes as the basis of therapeutic decision-making."

Our goal: To quickly, specifically and scientifically correctly answer the question to support the physician or pharmacist in his therapy decision, respectively the advising of his customers.

Since these methods often contribute significantly to the diagnosis and treatment decisions, we represent an interface to all the other specialists at UKM

In urgent cases (for example, ongoing pregnancy, therapy decision in case of a breast cancer disease dependent on a genetic examination), an appointment can also be agreed upon at short notice.

Antitachycardiac stimulators, in particular ICDs, known from the prior art employ a variety of rhythmological counters and ECG morphology criteria to control the antitachycardiac therapy in the VT zones in order to derive a decision on the therapy.

Contrary to known implantable electronic therapy devices, the device according to one or more embodiments of the invention is therefore designed to administer an antitachycardiac therapy, in particular a shock therapy, only when the tachycardia can indeed result in hemodynamic impairment, by capturing not only the heart rate, but also contractility and including it in the therapy decision.

One or more embodiments of the invention includes the observation that all known solutions have the disadvantage that either only the origin of the tachycardia or the duration of the tachycardia can be evaluated for the therapy decision.

Nevertheless, serological antibody diagnostics is utilized as a crucial aid in diagnosing and represents the basis of therapeutic decisions particularly in the event of indeterminate colitis.